# üß¨ Biofilm Detection on Corneal Tissue using SERS + Machine Learning  

This project combines **Surface-Enhanced Raman Spectroscopy (SERS)** with **machine learning** to detect **Pseudomonas aeruginosa (PA01) biofilms** on **pig corneal tissue**.  
It is the **first known application of SERS + ML for corneal biofilm diagnostics**, achieving **~92.5% accuracy** with perfect specificity.  

In addition to classification, the project includes **silver nanoparticle synthesis optimization** validated using **ANOVA** and **Fisher‚Äôs test**.  

![Python](https://img.shields.io/badge/Python-3.11-blue?logo=python)
![scikit-learn](https://img.shields.io/badge/ML-scikit--learn-orange)
![PCA](https://img.shields.io/badge/Dimensionality%20Reduction-PCA-critical)
![KMeans](https://img.shields.io/badge/Clustering-KMeans-lightgrey)
![SVM](https://img.shields.io/badge/Classifier-SVM-blueviolet)
![SERS](https://img.shields.io/badge/Spectroscopy-SERS-teal)
![airPLS](https://img.shields.io/badge/Baseline-airPLS-green)
![Savitzky‚ÄìGolay](https://img.shields.io/badge/Smoothing-Savitzky‚ÄìGolay-brightgreen)
![ANOVA](https://img.shields.io/badge/Stats-ANOVA-yellow)
![Fisher%20Test](https://img.shields.io/badge/Stats-Fisher%20Test-9cf)

---

## üß© Problem Statement  

Corneal biofilm infections are difficult to detect early due to weak Raman signals and tissue heterogeneity.  
Traditional diagnostic methods are **slow, invasive, and time-consuming**, leading to delayed treatment and higher risk of vision loss.  

This project demonstrates that combining **nanoparticle-enhanced Raman spectroscopy** with **machine learning** can deliver an **accurate, non-invasive diagnostic approach**.  

---

## üìä Dataset  

- **Samples**: Pig cornea inoculated with or without PA01 biofilm  
- **Spectra**: ~1024 wavenumber intensity points per sample  
- **Preprocessing**: interpolation ‚Üí baseline correction (**airPLS**) ‚Üí smoothing (**Savitzky‚ÄìGolay**) ‚Üí normalization  
- **Classes**:  
  - `0 = bacteria absent`  
  - `1 = bacteria present`  

---

## ‚öôÔ∏è Workflow  

<img src="visuals/workflow.png" width="800">  

**End-to-end workflow:**  
- *Left*: Corneal prep and SERS acquisition with optimized nanoparticles  
- *Middle (highlighted)*: Preprocessing ‚Üí PCA ‚Üí KMeans ‚Üí SVM classification pipeline  
- *Right*: Validation using sensitivity, specificity, and accuracy  

---

## üé® Visuals  

### 1. Experimental Setup & Nanoparticle Validation  

- **SERS setup schematic**  
  Experimental configuration for capturing Raman spectra from corneal tissue using silver nanoparticles.  
  <img src="visuals/figure4.png" width="600">  

- **Nanoparticle synthesis**  
  Colloidal silver nanoparticles confirmed with UV-Vis absorption spectra.  
  <img src="visuals/figure6.png" width="500">  

- **Enhancement calculations**  
  Quantification of Raman signal amplification achieved with nanoparticles.  
  <img src="visuals/figure7.png" width="500">  

- **Optimization experiments**  
  Signal strength across different nanoparticle concentrations and interaction times. ANOVA + Fisher test confirmed the optimized condition was statistically significant.  
  <img src="visuals/figure8.png" width="500">  
  <img src="visuals/figure9.png" width="500">  

---

### 2. Spectral Signatures (Raw vs Preprocessed)  

- **Spectrum without biofilm**  
  Raman spectrum of corneal tissue without PA01 biofilm (control).  
  <img src="visuals/figure20.png" width="500">  

- **Spectrum with biofilm**  
  Raman spectrum of corneal tissue with PA01 biofilm present.  
  <img src="visuals/figure21.png" width="500">  

- **Raw biofilm spectrum**  
  Example of an unprocessed spectrum showing baseline drift and noise.  
  <img src="visuals/figure25.png" width="500">  

- **Preprocessed spectrum**  
  After baseline correction (airPLS) and smoothing (Savitzky‚ÄìGolay), the signal is cleaner and comparable across samples.  
  <img src="visuals/figure26.png" width="500">  

---

### 3. Dimensionality Reduction & Clustering  

- **PCA variance explained**  
  ~30 principal components capture >95% of the variance, reducing dimensionality from 1024 features.  
  <img src="visuals/figure27.png" width="600">  

- **PCA visualization**  
  Spectral data separates along PCA axes, showing intrinsic group differences.  
  <img src="visuals/figure17.png" width="500">  

- **KMeans clustering**  
  Clustering accounts for intra-sample variability before classification.  
  <img src="visuals/figure18.png" width="500">  

---

### 4. Classification & Results  

- **Performance metrics**  
  Comparison of model performance across variants. The final pipeline (SVM + PCA + KMeans) achieved 92.5% accuracy with perfect specificity.  
  <img src="visuals/figure22.png" width="600">  

- **Confusion matrices**  
  Breakdown of classification outcomes: perfect specificity (no false positives) and strong sensitivity.  
  - Counts / percentages  
    <img src="visuals/confusion_matrix.png" width="360">  
  - Normalized (0‚Äì1)  
    <img src="visuals/confusion_matrix_normalized.png" width="360">  

---

## üìà Key Results  

| Model Variant             | Sensitivity | Specificity | Accuracy |
|---------------------------|-------------|-------------|----------|
| SVM only                  | 50%         | 100%        | 75.0%    |
| SVM + PCA                 | 62.5%       | 100%        | 81.3%    |
| **SVM + PCA + KMeans**    | **80%**     | **100%**    | **92.5%** |

---

## üí° Key Insights  

- **Novelty**: First demonstration of **SERS + ML on corneal tissue** for biofilm detection  
- **Nanoparticle validation**: Optimization statistically validated with ANOVA + Fisher test  
- **ML pipeline**: PCA + KMeans preprocessing improved classification robustness  
- **Performance**: 92.5% accuracy with perfect specificity  
- **Clinical impact**: Potential pathway for **fast, non-invasive ocular diagnostics**  

---

## üöÄ Next Steps  

- Expand dataset with **different bacterial strains**  
- Extend to **human corneal samples**  
- Explore **deep learning models** for Raman spectra  
- Develop **point-of-care diagnostic prototype**  

---

## üìö Thesis 

- **Published version (DOI)**: see [``]()  

---

## ‚öñÔ∏è Disclaimer  

This project is for **academic and portfolio purposes only**. It is **not** intended for direct clinical use.  
